IPF
Clinical trials for IPF explained in plain language.
Never miss a new study
Get alerted when new IPF trials appear
Sign up with your email to follow new studies for IPF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new lung scarring drug shows early safety profile
Disease control CompletedThis early-stage study tested a new drug called PMG1015 in 29 people with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. The main goal was to check the drug's safety, side effects, and how it moves through the body at different doses. Researchers compared t…
Matched conditions: IPF
Phase: PHASE1 • Sponsor: Pulmongene Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill tested to slow scarring in lungs
Disease control CompletedThis study tested whether a daily oral pill called GRI-0621 is safe and can affect markers of disease in people with IPF, a condition that causes progressive lung scarring. About 35 participants took either the study drug or a placebo pill for 12 weeks. The main goal was to check…
Matched conditions: IPF
Phase: PHASE2 • Sponsor: GRI Bio Operations, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Experimental drug tested to slow scarring lung disease
Disease control CompletedThis study tested whether an oral drug called MN-001 could help control idiopathic pulmonary fibrosis (IPF), a serious disease that scars the lungs. Fifteen adults with moderate to severe IPF took either MN-001 or a placebo pill twice daily for six months, followed by another six…
Matched conditions: IPF
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
First human test of new drug begins
Knowledge-focused CompletedThis was the first study in people to test the safety of a new drug called HLX6018. It involved 66 healthy volunteers who received a single dose to check for side effects and see how the drug moves through the body. The goal was to gather basic safety information before testing i…
Matched conditions: IPF
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Knowledge-focused
Last updated Apr 02, 2026 01:56 UTC
-
Simple questions aim to get IPF patients faster, better care at home
Knowledge-focused CompletedThis study tested a short questionnaire designed to quickly identify the palliative care needs of people newly diagnosed with Idiopathic Pulmonary Fibrosis (IPF). Researchers gave the questionnaire to 30 patients to see if it could accurately match them to the right level of care…
Matched conditions: IPF
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Researchers test which score best predicts fate for scarred lungs
Knowledge-focused CompletedThis study looked back at medical records to see which of three scoring systems best predicts how long patients with different types of progressive lung scarring might live. Researchers analyzed data from 143 adults with specific lung diseases to compare the accuracy of the GAP, …
Matched conditions: IPF
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC